## **Core Concept**
Glanzmann's thrombasthenia is a bleeding disorder characterized by the dysfunction of platelets, specifically affecting their ability to aggregate. This condition is associated with defects in certain platelet surface glycoproteins.

## **Why the Correct Answer is Right**
The correct answer, , refers to glycoprotein IIb/IIIa, also known as integrin αIIbβ3. This glycoprotein complex plays a crucial role in platelet aggregation by acting as a receptor for fibrinogen and von Willebrand factor, facilitating platelet-platelet bridging. In Glanzmann's thrombasthenia, there is a deficiency or dysfunction of this complex, leading to impaired platelet aggregation and increased bleeding tendency.

## **Why Each Wrong Option is Incorrect**
- **Option A:** - This option is incorrect because while abnormalities in von Willebrand factor (vWF) are associated with von Willebrand disease, Glanzmann's thrombasthenia specifically involves a defect in the platelet receptor for vWF and fibrinogen, not the vWF itself.
- **Option B:** - This option is incorrect as factor VIII is involved in hemophilia A, not Glanzmann's thrombasthenia.
- **Option C:** - This option might seem plausible due to its role in coagulation, but Glanzmann's thrombasthenia is specifically related to platelet function, not the coagulation cascade directly.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl for Glanzmann's thrombasthenia is that patients often present with mucocutaneous bleeding, such as purpura, epistaxis, and gingival bleeding, and may have a normal platelet count but abnormal platelet function. Laboratory diagnosis typically involves platelet aggregation studies showing impaired aggregation in response to certain agonists.

## **Correct Answer:** . Glycoprotein IIb/IIIa.